Structure |
Chemical Name |
CAS |
MF |
![Plerixafor Impurity D](/) |
Plerixafor Impurity D |
|
|
![methyl 1-phenylethanesulfonate](/CAS/20210111/GIF/883835-57-2.gif) |
methyl 1-phenylethanesulfonate |
883835-57-2 |
C9H12O3S |
![Cefuroxime impurity 1](/CAS/20200119/GIF/CB13127930.gif) |
Cefuroxime impurity 1 |
|
C16H16N4O8S |
![Vonoprazan Impurity 9](/) |
Vonoprazan Impurity 9 |
|
|
![Sitagliptin IMpurity 5](/) |
Sitagliptin IMpurity 5 |
|
|
![Brexpiprazole Impurity3](/) |
Brexpiprazole Impurity3 |
|
|
![Doxofylline Impurity 22](/) |
Doxofylline Impurity 22 |
|
|
![Levetiracetam impurity 5](/CAS/20200611/GIF/1543300-90-8.gif) |
Levetiracetam impurity 5 |
1543300-90-8 |
C9H17NO4 |
![Dapoxetine impurity 61](/) |
Dapoxetine impurity 61 |
|
|
![Febuxostat Impurity B](/) |
Febuxostat Impurity B |
|
|
![Sorafenib Impurity F](/) |
Sorafenib Impurity F |
|
|
![Trelagliptin Impurity 1](/CAS/20200611/GIF/1821400-07-0.gif) |
Trelagliptin Impurity 1 |
1821400-07-0 |
C21H13ClF2N4O2 |
![Vortioxetine Imp.J](/CAS/20200611/GIF/2137588-68-0.gif) |
Vortioxetine Imp.J |
2137588-68-0 |
C18H22N2S |
![Butyphthalide impurity 26](/) |
Butyphthalide impurity 26 |
|
|
![4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide](/CAS/20180629/GIF/1608459-56-8.gif) |
4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
1608459-56-8 |
C18H27N3O3 |
![4,5-dichloro Rivaroxaban](/CAS/20210111/GIF/2305917-61-5.gif) |
4,5-dichloro Rivaroxaban |
2305917-61-5 |
C25H28ClN3O6S |
![Solifenacin EP Impurity B](/CAS/20180808/GIF/1534326-81-2.gif) |
Solifenacin EP Impurity B |
1534326-81-2 |
C31H28N2O |
![Vildagliptin Impurity 6](/CAS/20200611/GIF/1846606-31-2.gif) |
Vildagliptin Impurity 6 |
1846606-31-2 |
C17H23N3O2 |
![Flucloxacillin Impurity A](/) |
Flucloxacillin Impurity A |
|
|
![Nicorandil Impurity 1](/) |
Nicorandil Impurity 1 |
|
|
![Piperacillin Impurity 6](/) |
Piperacillin Impurity 6 |
|
|
![Bosutinib Impurity 5](/CAS/20180808/GIF/1391063-17-4.gif) |
Bosutinib Impurity 5 |
1391063-17-4 |
C26H29Cl2N5O3 |
![Levomilnacipran impurity](/) |
Levomilnacipran impurity |
|
|
![Sofosbuvir IMpurity 4](/) |
Sofosbuvir IMpurity 4 |
|
|
![1,3-bis(4-isobutylphenyl)butan-1-one](/CAS/20180702/GIF/CB13146797.gif) |
1,3-bis(4-isobutylphenyl)butan-1-one |
|
C24H32O |
![6-isobutyl-3-methyl-2,3-dihydro-1H-inden-1-one](/CAS/20180702/GIF/1340024-54-5.gif) |
6-isobutyl-3-methyl-2,3-dihydro-1H-inden-1-one |
1340024-54-5 |
C14H18O |
![2-(2-ピリジニルアミノ)グリオキシル酸エチル](/CAS/20180906/GIF/41374-72-5.gif) |
2-(2-ピリジニルアミノ)グリオキシル酸エチル |
41374-72-5 |
C9H10N2O3 |
![Canagliflozin Impurity 18](/) |
Canagliflozin Impurity 18 |
|
|
![Canagliflozin Impurity 23](/) |
Canagliflozin Impurity 23 |
|
|
![Carfilzomib Impurity 4](/) |
Carfilzomib Impurity 4 |
|
|
![Lenvatinib Impurity 2](/CAS/20200611/GIF/2380197-90-8.gif) |
Lenvatinib Impurity 2 |
2380197-90-8 |
C28H22ClN5O5 |
![FeBuxostat Impurity 33](/CAS/20180808/GIF/100118-38-5.gif) |
FeBuxostat Impurity 33 |
100118-38-5 |
C12H14O5 |
![(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)](/CAS/20210111/GIF/1642630-12-3.gif) |
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl) |
1642630-12-3 |
C22H22N6O |
![Latamoxef Impurity 1](/CAS/20210111/GIF/75007-70-4.gif) |
Latamoxef Impurity 1 |
75007-70-4 |
C19H20N6O7S |
![Amlodipine iMpurity K](/CAS/20180527/GIF/1809326-44-0.gif) |
Amlodipine iMpurity K |
1809326-44-0 |
C18H21ClN2O5 |
![Cabozantinib impurity 4](/CAS/20210111/GIF/95932-39-1.gif) |
Cabozantinib impurity 4 |
95932-39-1 |
C11H15NO3 |
![Rosuvastatin EP Impurity C](/CAS/20211123/GIF/1620823-61-1.gif) |
Rosuvastatin EP Impurity C |
1620823-61-1 |
C22H27FN3NaO6S |
![4-(フェニルアミノ)-6,7-ビス(2-メトキシエトキシ)キナゾリン](/CAS/20180527/GIF/1145671-52-8.gif) |
4-(フェニルアミノ)-6,7-ビス(2-メトキシエトキシ)キナゾリン |
1145671-52-8 |
C20H23N3O4 |
![(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate](/CAS/20180527/GIF/1052063-36-1.gif) |
(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate |
1052063-36-1 |
C14H24N2O4 |
![4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate](/CAS/20180527/GIF/941296-96-4.gif) |
4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate |
941296-96-4 |
C16H28N2O4 |
![Dapoxetine impurity 55](/) |
Dapoxetine impurity 55 |
|
|
![1-METHYLBIGUANIDE SULPHATE](/CAS/GIF/1609-00-3.gif) |
1-METHYLBIGUANIDE SULPHATE |
1609-00-3 |
C3H9N5 |
![1-(3,5-DIHYDROXYPHENYL)-2-[(1,1-DIMETHYLETHYL)AMINO]-ETHANONE, HYDROCHLORIDE](/StructureFile/ChemBookStructure8/GIF/CB2752536.gif) |
1-(3,5-DIHYDROXYPHENYL)-2-[(1,1-DIMETHYLETHYL)AMINO]-ETHANONE, HYDROCHLORIDE |
1246815-70-2 |
C12H18ClNO3 |
![4-(((2R,3S,4R,5R,6R)-6-(Benzyloxy)-3-((diphenoxyphosphoryl)oxy)-4-(tetradecanoyloxy)-5-((S)-3-(tetradecanoyloxy)tetradecanaMido)tetrahydro-2H-pyran-2-yl)Methoxy)-4-oxobutanoic acid](/CAS/GIF/110611-91-1.gif) |
4-(((2R,3S,4R,5R,6R)-6-(Benzyloxy)-3-((diphenoxyphosphoryl)oxy)-4-(tetradecanoyloxy)-5-((S)-3-(tetradecanoyloxy)tetradecanaMido)tetrahydro-2H-pyran-2-yl)Methoxy)-4-oxobutanoic acid |
110611-91-1 |
C71H110NO15P |
![Oxacillin Impurity H](/) |
Oxacillin Impurity H |
|
|
![(2S,3R)-3-(6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol](/) |
(2S,3R)-3-(6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
|
|
![PeraMpanel](/CAS/20210111/GIF/380918-54-7.gif) |
PeraMpanel |
380918-54-7 |
C23H15N3O |
![Butyphthalide impurity 32](/) |
Butyphthalide impurity 32 |
|
|
![Canagliflozin Impurity 30](/) |
Canagliflozin Impurity 30 |
|
|
![Celecoxib Impurity 20](/CAS/20200401/GIF/343853-74-7.gif) |
Celecoxib Impurity 20 |
343853-74-7 |
C6H7N3O3S |
![Emtricitabine Impurity CFTU1](/) |
Emtricitabine Impurity CFTU1 |
|
|
![Febuxostat Impurity 82](/) |
Febuxostat Impurity 82 |
|
|
![Febuxostat Impurity 87](/) |
Febuxostat Impurity 87 |
|
|
![Gefitinib Impurity R](/) |
Gefitinib Impurity R |
|
|
![Cabozantinib impurity 75](/) |
Cabozantinib impurity 75 |
|
|
![Cabozantinib impurity 73](/) |
Cabozantinib impurity 73 |
|
|
![Canagliflozin Impurity 69](/) |
Canagliflozin Impurity 69 |
|
|
![Dapoxetine impurity 65](/) |
Dapoxetine impurity 65 |
|
|
![Dapoxetine impurity 59](/) |
Dapoxetine impurity 59 |
|
|
![PeraMpanel](/CAS/20210111/GIF/380919-34-6.gif) |
PeraMpanel |
380919-34-6 |
C23H17N3O2 |
![Empagliflozin Impurity 83](/) |
Empagliflozin Impurity 83 |
|
|
![Ambroxol Imp.O](/CAS/20210111/GIF/1807328-39-7.gif) |
Ambroxol Imp.O |
1807328-39-7 |
C13H12Br2N2O |
![Olopatadine Impurity 10 HBr](/CAS/20211123/GIF/4174-83-8.gif) |
Olopatadine Impurity 10 HBr |
4174-83-8 |
C22H26Br2NP |
![Iohexol Impurity Q](/) |
Iohexol Impurity Q |
|
|
![(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid](/CAS/20180629/GIF/CB13159054.gif) |
(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid |
|
C8H8FN3O4S |
![Amlodipine Impurity 10](/CAS/20180629/GIF/CB13159160.gif) |
Amlodipine Impurity 10 |
2170104-51-3 |
C26H31ClN2O8S |
![Clopidogrel Impurity 8](/CAS/20180629/GIF/CB13159236.gif) |
Clopidogrel Impurity 8 |
|
C15H14ClNO2S |
![Nilotinib genotoxic impurity 3](/CAS/20200611/GIF/915711-42-1.gif) |
Nilotinib genotoxic impurity 3 |
915711-42-1 |
C19H17F3N4O |
![Dapagliflozin Open Ring](/CAS/20200611/GIF/2100872-88-4.gif) |
Dapagliflozin Open Ring |
2100872-88-4 |
C21H27ClO7 |
![Rortezide impurity](/) |
Rortezide impurity |
|
|
![Cabozantinib Impurity A](/) |
Cabozantinib Impurity A |
|
|
![Loxoprofen Impurity E](/) |
Loxoprofen Impurity E |
|
|
![(R)-4-Propylpyrrolidin-2-one](/CAS/20180527/GIF/930123-37-8.gif) |
(R)-4-Propylpyrrolidin-2-one |
930123-37-8 |
C7H13NO |
![Rocuronium Bromide Intermediate B Impurity E-1](/CAS/20180808/GIF/1190105-60-2.gif) |
Rocuronium Bromide Intermediate B Impurity E-1 |
1190105-60-2 |
C29H48N2O3 |
![4-Chloro-2-propylsulfanyl-pyrimidine](/CAS/20180527/GIF/1351990-36-7.gif) |
4-Chloro-2-propylsulfanyl-pyrimidine |
1351990-36-7 |
C7H9ClN2S |
![benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate](/CAS/20200611/GIF/1194550-67-8.gif) |
benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate |
1194550-67-8 |
C36H30Cl2N2O7S |
![D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]-](/CAS/20180528/GIF/119238-52-7.gif) |
D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]- |
119238-52-7 |
C9H15NO3S |
![2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI)](/CAS/20200119/GIF/145281-92-1.gif) |
2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI) |
145281-92-1 |
C8H9FN2O4S |
![Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]-](/CAS/20180529/GIF/15026-80-9.gif) |
Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]- |
15026-80-9 |
C11H19NO3 |
![L-Phenylalanine, N-L-leucyl-, methyl ester](/CAS/20180529/GIF/38155-18-9.gif) |
L-Phenylalanine, N-L-leucyl-, methyl ester |
38155-18-9 |
C16H24N2O3 |
![Ethanol, 2-[(2-chloroethyl)amino]-](/CAS/20180529/GIF/3890-98-0.gif) |
Ethanol, 2-[(2-chloroethyl)amino]- |
3890-98-0 |
C4H10ClNO |
![2-[(2-フリルメチル)アミノ]-5-スルファモイル安息香酸](/CAS/20180531/GIF/4818-85-3.gif) |
2-[(2-フリルメチル)アミノ]-5-スルファモイル安息香酸 |
4818-85-3 |
C12H12N2O5S |
![4(1H)-Pyridinone, 2-(hydroxymethyl)-3,5-dimethyl- (9CI)](/CAS/GIF/220757-73-3.gif) |
4(1H)-Pyridinone, 2-(hydroxymethyl)-3,5-dimethyl- (9CI) |
220757-73-3 |
C8H11NO2 |
![Rocuronium Bromide Impurity 19 、21、22](/) |
Rocuronium Bromide Impurity 19 、21、22 |
|
|
![Flucloxacillin impurity D](/) |
Flucloxacillin impurity D |
|
|
![Ritonavir EP Impurity STU](/) |
Ritonavir EP Impurity STU |
|
|
![Letermovir Impurity 1](/) |
Letermovir Impurity 1 |
|
|
![Roxadustat Impurity 16](/) |
Roxadustat Impurity 16 |
|
|
![Perospirone Impurity 19](/) |
Perospirone Impurity 19 |
|
|
![IMp. A (EP): (RS)-2-Chloro-N-(2-Methylphenyl)-PropanaMide](/CAS/20150408/GIF/39084-88-3.gif) |
IMp. A (EP): (RS)-2-Chloro-N-(2-Methylphenyl)-PropanaMide |
39084-88-3 |
C10H11Cl2NO |
![1β-Hydroxy-6α-Methyl-1,4-androstadiene-3,17-dione](/CAS/GIF/61919-52-6.gif) |
1β-Hydroxy-6α-Methyl-1,4-androstadiene-3,17-dione |
61919-52-6 |
C20H26O3 |
![5-Fluoro ent-LaMivudine Acid D-Menthol Ester](/CAS/GIF/764659-79-2.gif) |
5-Fluoro ent-LaMivudine Acid D-Menthol Ester |
764659-79-2 |
C18H26FN3O4S |
![3,5,7-トリメチル-1-アダマンタンアミン・塩酸塩](/CAS/20150408/GIF/15210-60-3.gif) |
3,5,7-トリメチル-1-アダマンタンアミン・塩酸塩 |
15210-60-3 |
C13H24ClN |
![2,6-ジメチル-4-(2,3-ジクロロフェニル)-3,5-ピリジンジカルボン酸3-メチル5-(ブチリルオキシメチル)](/CAS/20150408/GIF/188649-48-1.gif) |
2,6-ジメチル-4-(2,3-ジクロロフェニル)-3,5-ピリジンジカルボン酸3-メチル5-(ブチリルオキシメチル) |
188649-48-1 |
C21H21Cl2NO6 |
![BIS VALACYCLOVIR (〜90%)](/CAS/GIF/1356019-51-6.gif) |
BIS VALACYCLOVIR (〜90%) |
1356019-51-6 |
C27H40N12O8 |
![Flupirtine DiMer](/CAS/20180808/GIF/1417916-52-9.gif) |
Flupirtine DiMer |
1417916-52-9 |
C30H32F2N8O4 |
![3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide](/CAS/20150408/GIF/CB42658629.gif) |
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
2304623-36-5 |
C16H14N2O3S |
![(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(M-tolyl)propan-1-aMine](/CAS/20150408/GIF/253337-60-9.gif) |
(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(M-tolyl)propan-1-aMine |
253337-60-9 |
C22H25N |
![3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide](/CAS/20150408/GIF/CB42666835.gif) |
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide |
1675248-19-7 |
C16H22N6O2 |
![Blonanserin iMpurity](/CAS/20180808/GIF/132810-83-4.gif) |
Blonanserin iMpurity |
132810-83-4 |
C23H30FN3 |